Santé

Avis sur la proposition modifiée de directive de la Commission relative à la transparence des mesures régissant la fixation des prix des médicaments à usage humain et leur inclusion dans le champ d’application des systèmes publics d’assurance-maladie

In the course of 2012, we once again set new benchmarks in different areas of activity. In the supervision of EU institutions and bodies, when processing personal data, we interacted with more data protection officers in more institutions and bodies than ever before. In addition, we saw the effects of our new enforcement policy: most EU institutions and bodies, including many agencies, are making good progress in complying with the Data Protection Regulation, although there are still some which should increase their efforts.

In the consultation of new legislative measures, we issued a record number of opinions on a wide range of subjects. The Review of the EU legal framework for data protection was at the top of our agenda. However, the implementation of the Stockholm programme in the area of freedom, security and justice and the Digital Agenda, as well as issues in the internal market, such as financial sector reform and in public health and consumer affairs, also had an impact on data protection. We also increased our cooperation with other supervisory authorities.

Vous pouvez obtenir une version papier de ce rapport annuel sur EU Bookshop.

Avis sur la communication de la Commission relative au 'Plan d'action 2012-2020 - Améliorer les soins de santé pour les citoyens européens: plan d'action pour un espace européen de la santé en ligne'